Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine ...

Cancer remains one of humanity's most formidable challenges, claiming the lives of millions every year despite decades of medical progress. While some cancers respond well to treatment when diagnosed ...

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic ...

Pancreatic cancer has one of the poorest prognoses among cancers, ranking as the 6th leading cause of cancer mortality worldwide 1. With a five-year survival rate of just 13%, underscoring the ...

A new breath test for pancreatic cancer could “revolutionise” treatment for the disease, experts have said. Scientists at ...

Pancreatic cancer incidence is rising among younger adults, particularly those aged 15 to 39, due to lifestyle and genetic factors. Key risk factors include obesity, smoking, alcohol consumption, and ...

National Awareness Initiative Elevates Primary Care Voices to Drive Early DetectionNew York, NY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- In recognition of World Pancreatic Cancer Month in November 2025, ...

Atebimetinib combined with modified chemotherapy achieved a 94% six-month overall survival rate in first-line pancreatic cancer patients, surpassing the typical 67% with standard treatment. The ...

Pancreatic cancer is a highly aggressive disease -- only 13% of patients typically survive five years after diagnosis. Early detection is so difficult. Here's one major symptom to watch for. It’s a ...

As the incidence of obesity continues to rise nationally and globally, a new observational study published in Cancer reports ...

LOS ANGELES (CNS) -- A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify ...